Use of systemic immunomodulating medications in pregnant women with atopic dermatitis: A nationwide US study.
作者信息
Schoder Katharina, Zhu Yanmin, Schneeweiss Sebastian, Merola Joseph F, Savage Timothy J, Gibbs Liza R, Schneeweiss Maria C
机构信息
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Institute for Medical Information Processing, Biometry and Epidemiology - IBE, LMU Munich, Munich, Germany; Pettenkofer School of Public Health, Munich, Germany.
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
出版信息
J Am Acad Dermatol. 2023 Jul;89(1):178-181. doi: 10.1016/j.jaad.2023.02.047. Epub 2023 Mar 10.
Abstract
摘要
相似文献
1
Use of systemic immunomodulating medications in pregnant women with atopic dermatitis: A nationwide US study.美国一项全国性研究：特应性皮炎孕妇使用全身性免疫调节药物的情况。
J Am Acad Dermatol. 2023 Jul;89(1):178-181. doi: 10.1016/j.jaad.2023.02.047. Epub 2023 Mar 10.
2
Reported Pregnancy Outcomes in Women With Severe Atopic Dermatitis Treated With Dupilumab: A Systematic Review.使用度普利尤单抗治疗的重度特应性皮炎女性的妊娠结局报告：一项系统评价
J Cutan Med Surg. 2023 Mar-Apr;27(2):177-178. doi: 10.1177/12034754231152223. Epub 2023 Jan 31.
3
Joint pain in patients with atopic dermatitis receiving treatment with dupilumab: A US nationwide cohort study.接受度普利尤单抗治疗的特应性皮炎患者的关节疼痛：一项美国全国性队列研究。
J Am Acad Dermatol. 2024 Jan;90(1):134-137. doi: 10.1016/j.jaad.2023.08.025. Epub 2023 Aug 19.
4
Longitudinal utilization of systemic immunomodulators before and after dupilumab approval in children with atopic dermatitis.特应性皮炎患儿在度普利尤单抗获批前后系统性免疫调节剂的纵向使用。
Pediatr Dermatol. 2023 Jan;40(1):132-134. doi: 10.1111/pde.15172. Epub 2022 Nov 20.
5
EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers.湿疹面积和严重程度指数（EASI）与改良湿疹面积和严重程度指数（p-EASI）：使用血清生物标志物组合预测接受度普利尤单抗治疗的特应性皮炎患者的疾病严重程度
Allergy. 2020 Dec;75(12):3287-3289. doi: 10.1111/all.14492. Epub 2020 Jul 24.
6
Successful dose reduction of dupilumab in atopic dermatitis.度普利尤单抗在特应性皮炎中成功降低剂量
Br J Dermatol. 2023 Apr 20;188(5):678-679. doi: 10.1093/bjd/ljad011.
7
Dose reduction of dupilumab in atopic patients with controlled atopic dermatitis: A safe and effective practice?度普利尤单抗在特应性皮炎得到控制的特应性患者中减量：一种安全有效的做法？
J Eur Acad Dermatol Venereol. 2023 May;37(5):e691-e692. doi: 10.1111/jdv.18908. Epub 2023 Feb 6.
8
Dupilumab for atopic dermatitis during pregnancy and breastfeeding: Clinical experience in 13 patients.度普利尤单抗用于孕期及哺乳期特应性皮炎：13例患者的临床经验
J Eur Acad Dermatol Venereol. 2023 Sep;37(9):e1156-e1160. doi: 10.1111/jdv.19165. Epub 2023 May 12.
9
Real-life long-term efficacy of dupilumab in adults with moderate to severe atopic dermatitis: Results of a cohort study.度普利尤单抗治疗中度至重度特应性皮炎成人患者的真实世界长期疗效：一项队列研究的结果
Ann Dermatol Venereol. 2023 Sep;150(3):215-216. doi: 10.1016/j.annder.2023.06.004. Epub 2023 Aug 17.
10
Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis.在成人特应性皮炎患者使用度普利尤单抗前后，研究美国全身性免疫调节剂的使用模式。
Pharmacoepidemiol Drug Saf. 2023 May;32(5):567-576. doi: 10.1002/pds.5586. Epub 2022 Dec 28.
引用本文的文献
1
Safety of Dupilumab Therapy for Atopic Dermatitis during Pregnancy: A Systematic Review and Meta-analysis.度普利尤单抗治疗妊娠期间特应性皮炎的安全性：一项系统评价和荟萃分析。
Acta Derm Venereol. 2025 Feb 12;105:adv41307. doi: 10.2340/actadv.v105.41307.
本文引用的文献
1
Validation of ICD-10-CM Diagnosis Codes for Gestational Age at Birth.ICD-10-CM 出生时胎龄诊断编码的验证。
Epidemiology. 2023 Jan 1;34(1):64-68. doi: 10.1097/EDE.0000000000001557. Epub 2022 Sep 27.
2
European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period.欧洲特应性皮炎工作组立场文件：特应性皮炎父母在备孕、妊娠和哺乳期的治疗。
J Eur Acad Dermatol Venereol. 2019 Sep;33(9):1644-1659. doi: 10.1111/jdv.15709. Epub 2019 Jun 23.
3
Graphical Depiction of Longitudinal Study Designs in Health Care Databases.图形化展示医疗数据库中的纵向研究设计。
Ann Intern Med. 2019 Mar 19;170(6):398-406. doi: 10.7326/M18-3079. Epub 2019 Mar 12.
4
Dupilumab: human monoclonal antibody against IL-4Rα for moderate to severe atopic dermatitis.度普利尤单抗：用于中重度特应性皮炎的抗白细胞介素-4受体α人源单克隆抗体。
Drugs Today (Barc). 2017 Sep;53(9):477-487. doi: 10.1358/dot.2017.53.9.2693150.
Zotero 插件